1992
DOI: 10.1016/0140-6736(92)91745-t
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of hypercholesterolaemia in children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0
3

Year Published

1995
1995
2007
2007

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(13 citation statements)
references
References 2 publications
0
10
0
3
Order By: Relevance
“…Elas inibem parcialmente a HMG-CoA redutase, diminuindo a síntese do colesterol, o que leva ao aumento da formação de receptores de LDL. Diminuem também a formação de VLDL e apoB 11,14,20,21 . O emprego de lovastatina e de sinvastatina em crianças e adolescentes com CT >300mg/dL mostrouse eficaz e seguro nas investigações de Ducobu e col 20 e de Sinzinger e col 21 .…”
Section: Terapêutica Para Dislipidemias Primáriasunclassified
See 2 more Smart Citations
“…Elas inibem parcialmente a HMG-CoA redutase, diminuindo a síntese do colesterol, o que leva ao aumento da formação de receptores de LDL. Diminuem também a formação de VLDL e apoB 11,14,20,21 . O emprego de lovastatina e de sinvastatina em crianças e adolescentes com CT >300mg/dL mostrouse eficaz e seguro nas investigações de Ducobu e col 20 e de Sinzinger e col 21 .…”
Section: Terapêutica Para Dislipidemias Primáriasunclassified
“…Diminuem também a formação de VLDL e apoB 11,14,20,21 . O emprego de lovastatina e de sinvastatina em crianças e adolescentes com CT >300mg/dL mostrouse eficaz e seguro nas investigações de Ducobu e col 20 e de Sinzinger e col 21 . Ducobu e col 20 , em 22 pacientes do sexo masculino e 10 do feminino e idade inferior a 17 anos, apresentando CT >300mg/dL após dieta, administraram sinvastatina na dose de 5 a 20g/dia aos menores de 10 anos e de 10 a 20g/dia aos maiores de 10 anos, durante 24-36 meses.…”
Section: Terapêutica Para Dislipidemias Primáriasunclassified
See 1 more Smart Citation
“…13,14 The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are effective, safe, and well-tolerated lipid-altering agents that have been proven to significantly reduce the incidence of CHD, stroke, and peripheral vascular disease in adults. 15,16 Thus far, there have only been a few studies evaluating statins in children, [17][18][19][20][21][22][23] but these studies were either not randomized or controlled, they included only boys, they had a modest sample size, or they were of short duration. The present study was designed to evaluate the LDL-C-lowering efficacy of simvastatin in a large cohort of both boys and girls with heFH to determine the overall safety and tolerability of simvastatin and to assess the influence of simvastatin on growth and pubertal development.…”
mentioning
confidence: 99%
“…Two studies appearing in 1992 reported that simvastatin and lovastatin appeared to be safe in children and had no adverse effects on growth [65]. Two larger studies of statins in children were published in 1996.…”
Section: Hmg-coa Reductase Inhibitors or Statinsmentioning
confidence: 97%